ClinVar Miner

Submissions for variant NC_012920.1(MT-TF):m.622G>A

dbSNP: rs118203887
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Mitochondrial Disease Nuclear and Mitochondrial Variant Curation Expert Panel, ClinGen RCV002247289 SCV005187321 uncertain significance Mitochondrial disease 2024-06-24 reviewed by expert panel curation The m.622G>A variant in MT-TF has been reported in one individual to date, in a woman with adult-onset myopathy and neuropathy. She was healthy until her early 60s when she developed exercise intolerance, fatigue, paresthesia, muscle cramps, and mild hearing impairment. Muscle biopsy showed several atrophic fibers, COX-deficient fibers, subsarcolemmal mitochondrial accumulation, and enlarged mitochondria with paracrystalline inclusions. She had reductions in complex I (50% controls), complex III (68% controls), and complex IV (55% controls) activities. The variant was present at 88% heteroplasmy in muscle, 70% in hair, 66% in urine, 63% in buccal sample, and 36% in blood (PMID: 16769874). Her mother was reported to have similar walking difficulties but did not undergo testing for this variant. Her healthy daughter had the variant present at lower heteroplasmy levels however her daughter was younger than the proband was at symptom onset. This variant is present in population databases (absent in Mitomap's GenBank sequences; one heteroplasmic and one homoplasmic occurrence in gnomAD v3.1.2; eight heteroplasmic occurrences in the Helix dataset). Single fiber testing showed higher levels of the variant in COX-negative fibers (93%±1.0; N = 11) than in COX-positive fibers (82%±8.5; N = 14), p<0.001 (PS3_supporting, PMID: 16769874). Aminoacylation defects and tRNA structural changes were also reported (PMID: 17878308). The computational predictor MitoTIP suggests this variant is neutral (41.5 percentile) and HmtVAR predicts it to be deleterious with a score of 0.7. In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on June 24, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS3_supporting.
Mendelics RCV002247289 SCV002517693 pathogenic Mitochondrial disease 2022-05-04 criteria provided, single submitter clinical testing
OMIM RCV000010188 SCV000030411 pathogenic Myopathy, mitochondrial, late-onset 2006-06-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.